Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study.

نویسندگان

  • Gaku Nakazawa
  • Aloke V Finn
  • Michael Joner
  • Elena Ladich
  • Robert Kutys
  • Erik K Mont
  • Herman K Gold
  • Allen P Burke
  • Frank D Kolodgie
  • Renu Virmani
چکیده

BACKGROUND The long-term safety of drug-eluting stents (DES) for acute myocardial infarction (AMI) remains uncertain. Using autopsy data, we evaluated the pathological responses of the stented segment in patients treated with DES for AMI and compared with patients with stable angina. METHODS AND RESULTS From the CVPath Registry of 138 DES autopsies, we identified 25 patients who presented with AMI and had an underlying necrotic core with a ruptured fibrous cap. Twenty-six patients who had stable angina with thick-cap fibroatheroma treated by DES were selected as controls. Histomorphometric analysis was performed in patients with >30-day stent duration. We compared the response to stenting at the culprit site in these 2 groups and to nonculprit sites within each stent. Late stent thrombosis was significantly less frequent in stable (11%) than in AMI (41%; P=0.04) patients. Although neointimal thickness in the AMI culprit site was significantly less (median, 0.04 mm; interquartile range [IQR], 0.02 to 0.09 mm), the prevalence of uncovered struts (49%; IQR, 16% to 96%), fibrin deposition (63+/-28%), and inflammation (35%; IQR, 27% to 49%) were significantly greater compared with the culprit site in stable patients (neointimal thickness: 0.11 mm [IQR, 0.07 to 0.21 mm], P=0.008; uncovered struts: 9% [IQR, 0% to 39%], P=0.01; fibrin: 36+/-27%, P=0.008; inflammation, 17% [IQR, 7% to 25%], P=0.003) and the nonculprit site within each stent. CONCLUSIONS Vessel healing at the culprit site in AMI patients treated with DES is substantially delayed compared with the culprit site in patients receiving DES for stable angina, emphasizing the importance of underlying plaque morphology in the arterial response to DES. Our data suggest an increased risk of thrombotic complications in patients treated with DES for AMI.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Development of Novel Drug-Eluting Stents for Acute Myocardial Infarction

Delayed arterial healing at culprit sites after drug-eluting stent (DES) placement for acute myocardial infarction (AMI) is associated with increased risk of late stent thrombosis. The Korea Acute Myocardial Infarction Registry was established in commemoration of the 50th anniversary of Korea Circulation Society. Between November 2005 and December 2016, more than 62,000 patients were registered...

متن کامل

Drug eluting or bare metal stent for acute myocardial infarction: an issue of safety?

Despite the widespread use of coronary artery stenting for the treatment of ST-elevation acute myocardial infarction (STEMI), little information exists about the long-term outcomes of drug eluting stents (DES) in this setting. Although DES result in a marked reduction in the rate of restenosis, concern still exists about the long-term safety of this technology, especially with respect to late s...

متن کامل

Late stent thrombosis after drug-eluting stent implantation for acute myocardial infarction: a new red flag is raised.

Late stent thrombosis (ST) made headlines when investigators realized that clinical events related to late ST, although rare, carried a mortality rate of up to 45% and a nonfatal infarction rate of another 30% to 40%.1,2 These rates clearly were more than those seen after bare metal stent (BMS) implantation, as first shown prospectively in the randomized Basel Stent Kosten Effektivitäts Trial–L...

متن کامل

Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis.

BACKGROUND Intravascular ultrasound of drug-eluting stent (DES) thrombosis (ST) reveals a high incidence of incomplete stent apposition (ISA) and vessel remodeling. Autopsy specimens of DES ST show delayed healing and hypersensitivity reactions. The present study sought to correlate histopathology of thrombus aspirates with intravascular ultrasound findings in patients with very late DES ST. ...

متن کامل

Revealing the silver and red lining in drug-eluting stents with angioscopy.

Drug-eluting stents (DES) are widely used in percutaneous coronary intervention and have resulted in significant reductions in target-vessel revascularization as compared with bare-metal stents (BMS) in randomized, controlled trials and in unrestricted patient and lesion subsets.1,2 Comprehensive analyses have proven the safety of sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PE...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Circulation

دوره 118 11  شماره 

صفحات  -

تاریخ انتشار 2008